Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
Msystems
|
July 20, 2022
Predictable Changes in Eelgrass Microbiomes with Increasing Wasting Disease Prevalence across 23° Latitude in the Northeastern Pacific
Deanna S Beatty, Lillian R Aoki, Brendan Rappazzo, et al.
The Journal of Biological Chemistry
|
February 17, 2018
Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon
Afua A Akuffo, Aileen Y Alontaga, Rainer Metcalf, et al.
Biomedicines
|
February 24, 2024
L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Oluwaseyi E Oluwatola, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Dominique Abrahams, et al.
Ecology
|
January 23, 2025
Seagrass wasting disease prevalence and lesion area increase with invertebrate grazing across the northeastern Pacific
Lillian R Aoki, Carmen J Ritter, Deanna S Beatty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Frontiers in Immunology
|
December 3, 2025
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma
Lilit Karapetyan, Joel Kuriakose, Matthew C Perez, et al.
Blood
|
November 22, 2019
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
Lanzhu Yue, Vasundhara Sharma, Nathan P Horvat, et al.
Blood
|
May 14, 2020
Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes
Rebecca S Hesterberg, Matthew S Beatty, Ying Han, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
Msystems
|
July 20, 2022
Predictable Changes in Eelgrass Microbiomes with Increasing Wasting Disease Prevalence across 23° Latitude in the Northeastern Pacific
Deanna S Beatty, Lillian R Aoki, Brendan Rappazzo, et al.
The Journal of Biological Chemistry
|
February 17, 2018
Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon
Afua A Akuffo, Aileen Y Alontaga, Rainer Metcalf, et al.
Biomedicines
|
February 24, 2024
L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Oluwaseyi E Oluwatola, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Dominique Abrahams, et al.
Ecology
|
January 23, 2025
Seagrass wasting disease prevalence and lesion area increase with invertebrate grazing across the northeastern Pacific
Lillian R Aoki, Carmen J Ritter, Deanna S Beatty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Frontiers in Immunology
|
December 3, 2025
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma
Lilit Karapetyan, Joel Kuriakose, Matthew C Perez, et al.
Blood
|
November 22, 2019
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
Lanzhu Yue, Vasundhara Sharma, Nathan P Horvat, et al.
Blood
|
May 14, 2020
Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes
Rebecca S Hesterberg, Matthew S Beatty, Ying Han, et al.
Page
of 14